Domínguez F, Adler E, García-Pavía P. Alcoholic cardiomyopathy: an update. European Heart Journal. 2024;45(26):2294-2305. doi:10.1093/eurheartj/ehae362.
Amor-Salamanca A, Guzzo-Merello G, González-López E, et al. Prognostic Impact and Predictors of Ejection Fraction Recovery in Patients With Alcoholic Cardiomyopathy. Revista Española de Cardiología (English Edition). 2018;71(8):612-619. doi:10.1016/j.rec.2017.11.032.
Guzzo-Merello G, Segovia J, Dominguez F, et al. Natural History and Prognostic Factors in Alcoholic Cardiomyopathy. JACC: Heart Failure. 2015;3(1):78-86. doi:10.1016/j.jchf.2014.07.014.
Mirijello A, Tarli C, Vassallo GA, et al. Alcoholic cardiomyopathy: What is known and what is not known. European Journal of Internal Medicine. 2017;43:1-5. doi:10.1016/j.ejim.2017.06.014.
Gavazzi A, De Maria R, Parolini M, Porcu M. Alcohol abuse and dilated cardiomyopathy in men. American Journal of Cardiology. 2000;85(9):1114-1118. doi:10.1016/S0002-9149(00)00706-2.
Urbano-Marquez A, Estruch R, Navarro-Lopez F, Grau JM, Mont L, Rubin E. The effects of alcoholism on skeletal and cardiac muscle. New England Journal of Medicine. 1989;320(7):409-415. doi:10.1056/NEJM198902163200701.
Nicolás JM, Fernández-Solà J, Estruch R, et al. The effect of controlled drinking in alcoholic cardiomyopathy. Annals of Internal Medicine. 2002;136(3):192-200. doi:10.7326/0003-4819-136-3-200202050-00007.
Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC Guidelines for the management of cardiomyopathies. European Heart Journal. 2023;44(37):3503-3626. doi:10.1093/eurheartj/ehad194.
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2021;42(36):3599-3726. doi:10.1093/eurheartj/ehab368.
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation. 2022;145(18):e895-e1032. doi:10.1161/CIR.0000000000001063.